Wanbury Strengthens Coriminic Brand with Pediatric-Focused, Regulation-Aligned Launches

Wanbury Limited (WL) further strengthens its well-known brand - Coriminic, for children cold & sneezing usage, with launch of Coriminic CPM Drops (Chlorpheniramine Maleate) without combination of decongestant for pediatric/ children usage, to address the drug control notification restricting fixed-dose cold combinations in children under 4 years of age.

Alongside Corirninic CPM Drops, Wanbury is strengthening the Corirninic brand with Coriminic NS (Normal Saline) Nasal Drops, a non-systemic nasal decongestant solution designed to provide localised relief for children from nasal congestion, helping physicians navigate treatment options within government regulatory boundaries.

This launch comes in the context of recent advisories and regulatory restrictions issued by the Drugs Controller General of India (DCGI), which have limited the use of fixed-dose combinations, those containing Chlorpheniramine + Phenylephrine, in children below 4 years due to safety concerns.

This strategic move positions Wanbury to capture a significant share of the f 861 crore Cold Preparation Liquid market and navigate the restrictions laid by DCGI.

With this expansion, Wanbury is poised to further consolidate its presence in the fastgrowing children Cold Preparation Liquid market.

Coriminic CPM Drops key benefits:

- Provides targeted relief from allergic symptoms such as severe cold, blocked nose, and sneezing

- Aligns with current regulatory guidance and safety considerations

- Supports rational prescribing practices in pediatric/children care

This marks a first-of-its-kind India-focused initiative to reposition Chlorpheniramine in a safer, indication-driven format for pediatric/ children use.

Wanbury Limited is a pharmaceutical company focused on delivering high-quality, affordable healthcare solutions across key therapeutic segments, including pediatrics.

Shares of Wanbury Limited was last trading in BSE at Rs. 235.95 as compared to the previous close of Rs. 247.25. The total number of shares traded during the day was 1411 in over 16 trades.

The stock hit an intraday high of Rs. 244.50 and intraday low of 235.00. The net turnover during the day was Rs. 338277.00.

Source : Equity Bulls

Keywords

Wanbury INE107F01022 Pharmaceuticals CoriminicBrand